ERNA Stock Analysis: Buy, Sell, or Hold?
ERNA - Ernexa Therapeutics Inc. Common Stock
$0.20
-0.01 (-4.75%)
▼
5d:
-3.7%
30d:
-34.61%
90d:
-83.29%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 06, 2026
Get Alerted When ERNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ERNA shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: ERNA shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: ERNA is currently trading at $0.20, which is considered oversold relative to its 30-day fair value range of $0.23 to $0.31.
Technical Outlook: Technically, ERNA is in a strong downtrend. Immediate support is located at $0.18, while resistance sits at $0.28. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: ERNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.00 (+1396.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ERNA is in a strong downtrend. Immediate support is located at $0.18, while resistance sits at $0.28. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: ERNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.00 (+1396.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.23 -
$0.31
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.8%)
- BULLISH: Trading 1396.3% below Wall St target ($3.00)
Fair Price Analysis
30-Day Fair Range
$0.23 -
$0.31
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.18
Resistance Level
$0.29
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Wall Street Target
$3.00
(+1396.3%)
Revenue Growth (YoY)
-94.1%
Share & Embed Analysis
Last updated: April 02, 2026 8:27 PM ET
Data refreshes hourly during market hours. Next update: 9:27 PM
Data refreshes hourly during market hours. Next update: 9:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ERNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$132 | 58 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 60 HOLD |
